Metasphere Labs Inc.
LABZ
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -90.27% | -48.07% | 31.26% | 229.71% | 716.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.27% | -48.07% | 31.26% | 229.71% | 716.06% |
| Cost of Revenue | -85.65% | -36.49% | 23.93% | 215.69% | 512.15% |
| Gross Profit | -91.11% | -50.27% | 32.84% | 232.62% | 770.62% |
| SG&A Expenses | -15.74% | -8.72% | -68.10% | -80.86% | -84.19% |
| Depreciation & Amortization | -62.11% | -47.13% | -61.89% | -67.64% | -69.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.53% | -14.49% | -62.15% | -74.66% | -80.59% |
| Operating Income | -211.85% | -580.47% | 102.15% | 112.23% | 109.55% |
| Income Before Tax | -347.94% | 64.12% | 93.97% | 99.98% | 97.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -347.94% | 64.12% | 93.97% | 99.98% | 97.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 111.31% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -405.11% | 64.05% | 94.02% | 99.98% | 98.11% |
| EBIT | -211.85% | -580.47% | 102.15% | 112.23% | 109.55% |
| EBITDA | -193.94% | -333.57% | 104.65% | 114.42% | 111.52% |
| EPS Basic | 89.01% | 98.10% | 99.89% | 102.15% | 95.60% |
| Normalized Basic EPS | -161.22% | 93.42% | 100.48% | 104.78% | 100.78% |
| EPS Diluted | 87.93% | 97.96% | 99.65% | 101.99% | 95.48% |
| Normalized Diluted EPS | -182.19% | 93.43% | 99.83% | 104.45% | 100.58% |
| Average Basic Shares Outstanding | 143.85% | 554.19% | 1,520.85% | 1,118.22% | 800.43% |
| Average Diluted Shares Outstanding | 65.22% | 364.18% | 1,899.09% | 1,513.48% | 1,228.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |